Leonardo Biosystems, Inc. and NanoMedical Systems, Inc. (NMS), two emerging drug delivery companies, today announced that they have signed a development contract in which NMS will develop and establish a commercial process to manufacture nanoporous silicon particles for Leonardo's multi-stage drug delivery system.
The Institute of Microelectronics (IME), a research institute of the Agency for Science, Technology and Research (A*STAR), has announced plans to commercialize key innovations in silicon chips designed to support high speed, high bandwidth optical communications. These chips were developed as part of IME's Silicon Photonics research platform.
In recognition of the significant growth opportunity associated with the global battery marketplace, BASF is creating a new global business unit that will bring together its current and future battery-related electromobility activities.
This new facility provides Innovative Solutions Bulgaria, manufacturer of the BudgetSensors line of AFM probes and AFM calibration standards, with the much needed space for the expansion of its production capacity.
Selecta Biosciences, Inc., a biopharmaceutical company developing a new class of synthetic vaccines and immunotherapies, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability and pharmacodynamic profile of SEL-068, a nicotine vaccine candidate for smoking cessation and relapse prevention.
The Ben Franklin Technology Development Authority has approved $3.15 million to be used for the University Research Commercialization Grant Program to support nanotechnology research and development activities.
mPhase Technologies, Inc. has developed a technology that exploits the phenomenon of electrowetting or the ability to electronically manipulate the way liquids behave when in contact with a solid or porous surface.
Microfluidics expert, Dolomite, is delighted to announce its collaboration with Clearbridge BioMedics in the development of a novel instrument capable of detecting and isolating Circulating Tumour Cells from small quantities of whole, unprocessed blood.
Japanese Society of Microscopy has announced that Park Systems Japan will be the sponsor for its upcoming AFM Bio-Imaging Forum. Set to take place at WINC AICHI in Nagoya on Tuesday, December 27th, 2011, the forum will invite leading Japanese scientists and researchers who apply state of the art AFM techniques to study biophysics, biochemistry, and cell biology.
Park Systems has introduced the NX10, the world's most accurate AFM, as the flagship AFM of its new product line. Now available worldwide, the NX10 brings unparalleled imaging accuracy, scan speeds, and tip life to the next generation of researchers, all at an affordable price.
Nanda has developed a high-throughput, high-sensitivity defect inspection technology for semiconductor manufacturing. With this acquisition, Nanometrics adds a highly differentiated and leading-edge macro defect inspection technology to its portfolio of industry-leading metrology solutions.